Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.

Chawla B, Mahajan B, Oakley M, Majam VF, Belmonte A, Sedegah M, Shimp RL Jr, Kaslow DC, Kumar S.

Infect Immun. 2019 Sep 19;87(10). pii: e00236-19. doi: 10.1128/IAI.00236-19. Print 2019 Oct.

PMID:
31308085
2.

VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.

Doritchamou JY, Herrera R, Aebig JA, Morrison R, Nguyen V, Reiter K, Shimp RL, MacDonald NJ, Narum DL, Fried M, Duffy PE.

J Infect Dis. 2016 Aug 15;214(4):577-86. doi: 10.1093/infdis/jiw197. Epub 2016 May 18.

3.

Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle.

Shimp RL Jr, Rowe C, Reiter K, Chen B, Nguyen V, Aebig J, Rausch KM, Kumar K, Wu Y, Jin AJ, Jones DS, Narum DL.

Vaccine. 2013 Jun 19;31(28):2954-62. doi: 10.1016/j.vaccine.2013.04.034. Epub 2013 Apr 24.

4.

Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.

Miura K, Herrera R, Diouf A, Zhou H, Mu J, Hu Z, MacDonald NJ, Reiter K, Nguyen V, Shimp RL Jr, Singh K, Narum DL, Long CA, Miller LH.

Infect Immun. 2013 May;81(5):1491-501. doi: 10.1128/IAI.01414-12. Epub 2013 Feb 19.

5.

Immunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1.

Qian F, Reiter K, Zhang Y, Shimp RL Jr, Nguyen V, Aebig JA, Rausch KM, Zhu D, Lambert L, Mullen GE, Martin LB, Long CA, Miller LH, Narum DL.

PLoS One. 2012;7(6):e36996. doi: 10.1371/journal.pone.0036996. Epub 2012 Jun 4.

6.

Analysis of the conformation and function of the Plasmodium falciparum merozoite proteins MTRAP and PTRAMP.

Uchime O, Herrera R, Reiter K, Kotova S, Shimp RL Jr, Miura K, Jones D, Lebowitz J, Ambroggio X, Hurt DE, Jin AJ, Long C, Miller LH, Narum DL.

Eukaryot Cell. 2012 May;11(5):615-25. doi: 10.1128/EC.00039-12. Epub 2012 Mar 30.

7.

Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate.

Plassmeyer ML, Reiter K, Shimp RL Jr, Kotova S, Smith PD, Hurt DE, House B, Zou X, Zhang Y, Hickman M, Uchime O, Herrera R, Nguyen V, Glen J, Lebowitz J, Jin AJ, Miller LH, MacDonald NJ, Wu Y, Narum DL.

J Biol Chem. 2009 Sep 25;284(39):26951-63. doi: 10.1074/jbc.M109.013706. Epub 2009 Jul 24.

8.

Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedure.

Qian F, Aebig JA, Reiter K, Barnafo E, Zhang Y, Shimp RL Jr, Rausch KM, Jones DS, Zhu D, Lambert L, Mullen GE, Narum DL, Miller LH, Wu Y.

Microbes Infect. 2009 Mar;11(3):408-12. doi: 10.1016/j.micinf.2008.12.009. Epub 2008 Dec 27.

9.

Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure.

Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL Jr, Lambert L, Miller LH, Long CA, Saul A, Narum DL.

Mol Biochem Parasitol. 2009 Mar;164(1):45-56. doi: 10.1016/j.molbiopara.2008.11.006. Epub 2008 Nov 27.

10.

Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection.

Narum DL, Nguyen V, Zhang Y, Glen J, Shimp RL, Lambert L, Ling IT, Reiter K, Ogun SA, Long C, Holder AA, Herrera R.

Infect Immun. 2008 Nov;76(11):4876-82. doi: 10.1128/IAI.01717-07. Epub 2008 Aug 18.

11.

Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tag.

Shimp RL Jr, Martin LB, Zhang Y, Henderson BS, Duggan P, MacDonald NJ, Lebowitz J, Saul A, Narum DL.

Protein Expr Purif. 2006 Nov;50(1):58-67. Epub 2006 Jun 27.

PMID:
16884920
12.
13.
14.

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.

Stowers AW, Cioce V, Shimp RL, Lawson M, Hui G, Muratova O, Kaslow DC, Robinson R, Long CA, Miller LH.

Infect Immun. 2001 Mar;69(3):1536-46.

15.

Structural conformers produced during malaria vaccine production in yeast.

Stowers AW, Zhang Y, Shimp RL, Kaslow DC.

Yeast. 2001 Jan 30;18(2):137-50.

Supplemental Content

Loading ...
Support Center